New approaches to improve the efficacy and augment the NK cell infiltration of tumor have been made, including genetic manipulations (expressing IL-8 receptor [190] or tumor CD37 enzyme blockade [191]), using human pluripotent stem cells for better availability of the treatment [192] and improving the manufacturing conditions for a future clinical use [193]. The gene discussed is CD37; the disease is neoplasm.